Dicerna Pharmaceuticals reported $31.27M in Trade Debtors for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Debtors Change
Acceleron Pharma XLRN:US $ 25.21M 0.89M
Agenus AGEN:US $ 2.17M 1.02M
Alnylam Pharmaceuticals ALNY:US $ 610.63M 8.21M
Amgen AMGN:US $ 4423M 102M
Arrowhead Research ARWR:US $ 0.96M 8.05M
Biogen BIIB:US $ 2224.1M 103.2M
Bluebird Bio BLUE:US $ 0M 0.4M
Dicerna Pharmaceuticals DRNA:US $ 31.27M 4.79M
Gilead Sciences GILD:US $ 3925M 967M
GlaxoSmithKline GSK:LN 7.18B 440M
Immunogen IMGN:US $ 21.03M 1.47M
Intercept Pharmaceuticals ICPT:US $ 42.59M 1.04M
Intrexon XON:US $ 21.36M 0.93M
Karyopharm Therapeutics KPTI:US $ 17.84M 4.96M
Lexicon Pharmaceuticals LXRX:US 101K 294K
Macrogenics MGNX:US $ 7.15M 15.93M
Mirati Therapeutics MRTX:US $ 1.84M 0.47M
Regeneron Pharmaceuticals REGN:US $ 4173M 58.3M
Ultragenyx Pharmaceutical RARE:US $ 25.03M 1.94M